CJC‑1295 (No DAC) 5mg + Ipamorelin 5mg – Peptide Blend

This peptide blend combines CJC‑1295 (without DAC) and Ipamorelin into a single formulation designed for research involving growth hormone–related signaling pathways.

In laboratory settings, these peptides are studied for their interaction with receptor systems involved in growth hormone regulation and cellular signaling processes.

• CJC‑1295 (No DAC) is researched for its role as a growth hormone–releasing hormone (GHRH) analog and its interaction with receptor signaling pathways

• Ipamorelin is studied as a selective ghrelin receptor agonist, commonly used in research focused on peptide signaling and receptor activity

Together, this combination is used to explore coordinated signaling effects and pathway interactions in controlled research environments.

Contents:

• CJC‑1295 (No DAC) – 5mg

• Ipamorelin – 5mg

Details:

• Lyophilized powder

• ≥99% purity (HPLC verified)

• Store at -20°C, protected from light

• Batch-specific documentation available

For research use only. Not for human or veterinary use.